AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections

AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections

ObjectiveTo determine the efficacy, safety, and durability of the use of AHCC supplementation for 6 months to support the host immune system to clear high-risk human papillomavirus (HPV) infections. The AHCC supplement is a proprietary, standardized extract of cultured lentinula edodes mycelia (AHCC...

Full description

Bibliographic Details
Main Authors: Judith A. Smith, Anjali A. Gaikwad, Lata Mathew, Barbara Rech, Jonathan P. Faro, Joseph A. Lucci, Yu Bai, Randall J. Olsen, Teresa T. Byrd
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
AHCC
cancer prevention
cervical cancer
HPV
immunomodulation
interferon-beta
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.881902/full

Similar Items

Similar Items